/Companies

Molmart Ltd

1 known investors

Find your way into Molmart Ltd

Sign up to see every warm intro you have to Molmart Ltd

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Molmart Ltd team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

MolMart offers at-home genetic carrier screening via a saliva test for individuals and couples planning a family, delivering results through an app with expert support. It focuses on identifying inherited conditions that may affect a baby's health.

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
MOLMART LTD.
Company number
10303155
Status
Active
Company type
Private limited company
Incorporated
29 Jul 2016
Registered office
32a The Renold Building, Altrincham Street, Manchester, M1 7JR
Nature of business (SIC)
86900 — Other human health activities
Previous names
MM GENOMICS LIMITED (2016–2016)
Accounts
last made up to 31 Jul 2025 · next due 30 Apr 2027
Confirmation statement
last made up to 27 Feb 2026 · next due 13 Mar 2027

Current officers · 2

  • Markella Andrea Mikkelsen — director, appointed 29 Jul 2016
  • Deepbridge Ned Limited — corporate director, appointed 3 Apr 2024

Source: Companies House public register · retrieved 8 Nov 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Molmart Ltd do?
MolMart offers at-home genetic carrier screening via a saliva test for individuals and couples planning a family, delivering results through an app with expert support. It focuses on identifying inherited conditions that may affect a baby's health.
Who are Molmart Ltd's investors?
Molmart Ltd's investors include Deepbridge Capital.